| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,735,588 |
1,656,290 |
$46.43M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
988,981 |
945,646 |
$40.67M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
510,821 |
500,059 |
$29.81M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
441,996 |
406,946 |
$25.80M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
368,346 |
361,473 |
$20.91M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
203,497 |
199,532 |
$12.12M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,016,064 |
991,334 |
$8.14M |
| 99051 |
|
444,442 |
430,726 |
$2.78M |
| 90670 |
|
221,020 |
214,509 |
$2.21M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,867 |
5,322 |
$845K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
4,522 |
3,974 |
$591K |
| 99460 |
|
15,765 |
15,094 |
$585K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
83,758 |
81,589 |
$568K |
| 90461 |
|
532,304 |
502,516 |
$564K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
13,300 |
12,741 |
$512K |
| 90686 |
|
247,640 |
240,714 |
$507K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,833 |
2,577 |
$464K |
| 97802 |
|
24,029 |
22,928 |
$458K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
264,293 |
204,551 |
$446K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
2,542 |
2,303 |
$376K |
| 1160F |
|
1,999,182 |
1,878,089 |
$343K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,635 |
7,489 |
$335K |
| 83655 |
|
132,230 |
129,337 |
$325K |
| 2001F |
|
2,772,757 |
2,515,126 |
$325K |
| 99188 |
|
44,152 |
42,545 |
$285K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
22,253 |
21,909 |
$267K |
| 90716 |
|
124,210 |
121,062 |
$246K |
| 85018 |
|
332,785 |
325,401 |
$218K |
| 99381 |
|
3,839 |
3,666 |
$213K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
4,661 |
4,247 |
$209K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,177 |
7,914 |
$189K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
64,051 |
62,264 |
$185K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13,627 |
13,144 |
$177K |
| 36415 |
Collection of venous blood by venipuncture |
207,182 |
200,383 |
$169K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14,060 |
13,724 |
$152K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
28,485 |
14,926 |
$149K |
| 90651 |
|
76,521 |
74,610 |
$119K |
| 3074F |
|
1,125,452 |
1,073,433 |
$114K |
| 99383 |
|
1,927 |
1,893 |
$112K |
| 99462 |
|
4,446 |
3,848 |
$104K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,571 |
1,535 |
$101K |
| 99401 |
|
5,099 |
5,033 |
$94K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42,650 |
40,933 |
$93K |
| 3078F |
|
1,125,837 |
1,051,692 |
$91K |
| 93000 |
|
9,269 |
8,494 |
$90K |
| 94010 |
|
6,330 |
5,868 |
$84K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,108 |
3,016 |
$80K |
| 90707 |
|
119,536 |
116,451 |
$72K |
| 92558 |
|
14,573 |
13,839 |
$71K |
| 90633 |
|
139,758 |
136,043 |
$70K |
| 90697 |
|
45,869 |
44,592 |
$68K |
| 93325 |
|
3,148 |
2,855 |
$66K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
952 |
907 |
$60K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,176 |
1,096 |
$59K |
| 90715 |
|
16,494 |
16,106 |
$54K |
| 99243 |
|
492 |
462 |
$51K |
| 3008F |
|
1,522,170 |
1,427,900 |
$50K |
| 92552 |
|
3,611 |
3,270 |
$47K |
| 93320 |
|
2,536 |
2,299 |
$46K |
| 92551 |
|
341,284 |
318,652 |
$45K |
| 97803 |
|
2,200 |
2,160 |
$42K |
| 31231 |
|
286 |
283 |
$37K |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
3,408 |
3,199 |
$36K |
| 90648 |
|
197,903 |
192,049 |
$35K |
| 69000 |
|
276 |
253 |
$34K |
| 90677 |
|
46,941 |
46,087 |
$33K |
| 90621 |
|
14,150 |
13,735 |
$32K |
| 96127 |
|
208,906 |
196,805 |
$31K |
| 69210 |
|
2,288 |
1,792 |
$28K |
| 90680 |
|
152,523 |
148,976 |
$28K |
| 99205 |
Prolong outpt/office vis |
130 |
129 |
$27K |
| 81003 |
|
27,254 |
26,088 |
$27K |
| 99382 |
|
466 |
460 |
$25K |
| 0071A |
|
1,120 |
982 |
$25K |
| 99215 |
Prolong outpt/office vis |
398 |
379 |
$24K |
| 90619 |
|
10,518 |
10,010 |
$22K |
| 90734 |
|
38,747 |
37,590 |
$21K |
| 99177 |
|
457,406 |
426,640 |
$19K |
| 99384 |
|
338 |
326 |
$19K |
| 90723 |
|
138,281 |
134,327 |
$17K |
| 93304 |
|
363 |
325 |
$16K |
| 0072A |
|
638 |
590 |
$15K |
| 90656 |
|
18,839 |
18,760 |
$15K |
| 99000 |
|
40,547 |
37,470 |
$15K |
| 0001A |
|
920 |
797 |
$11K |
| 90696 |
|
20,554 |
20,081 |
$11K |
| 0002A |
|
445 |
386 |
$10K |
| 90685 |
|
5,570 |
5,228 |
$10K |
| 41010 |
|
70 |
67 |
$10K |
| 99221 |
|
169 |
167 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,766 |
2,561 |
$10K |
| 99490 |
Ccm add 20min |
278 |
276 |
$10K |
| 87081 |
|
19,550 |
19,061 |
$9K |
| 90688 |
|
9,045 |
8,738 |
$8K |
| 94760 |
|
21,319 |
18,612 |
$8K |
| 95012 |
|
1,757 |
1,634 |
$8K |
| 99223 |
Prolong inpt eval add15 m |
39 |
29 |
$8K |
| 69399 |
|
83 |
82 |
$7K |
| 80061 |
Lipid panel |
1,217 |
1,173 |
$7K |
| 90700 |
|
22,914 |
22,316 |
$7K |
| 91300 |
|
2,538 |
2,131 |
$7K |
| 82947 |
|
3,526 |
3,406 |
$6K |
| 30901 |
|
70 |
69 |
$6K |
| 94664 |
|
690 |
645 |
$6K |
| 96380 |
|
2,363 |
2,332 |
$6K |
| 92587 |
|
758 |
721 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
364 |
350 |
$5K |
| 87634 |
|
182 |
180 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
459 |
443 |
$5K |
| 99222 |
Initial hospital care, per day, moderate complexity |
54 |
52 |
$4K |
| 90681 |
|
187 |
168 |
$4K |
| 82948 |
|
961 |
834 |
$4K |
| A4627 |
Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler |
152 |
123 |
$4K |
| 90660 |
|
370 |
369 |
$4K |
| 99441 |
|
528 |
524 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
890 |
800 |
$3K |
| 99072 |
|
3,391 |
3,049 |
$3K |
| 93321 |
|
365 |
325 |
$3K |
| 99173 |
|
22,508 |
19,661 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
285 |
279 |
$2K |
| 92567 |
|
196 |
182 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
45 |
42 |
$2K |
| 94060 |
|
86 |
76 |
$2K |
| 90672 |
|
418 |
411 |
$2K |
| 82247 |
|
962 |
779 |
$2K |
| 93227 |
|
71 |
67 |
$1K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
11,100 |
10,115 |
$1K |
| 93307 |
|
42 |
39 |
$1K |
| 90698 |
|
2,454 |
2,410 |
$1K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
1,663 |
1,599 |
$1K |
| S9451 |
Exercise classes, non-physician provider, per session |
23,371 |
21,135 |
$1K |
| 17110 |
|
13 |
13 |
$988.43 |
| 99442 |
|
111 |
108 |
$744.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
234 |
185 |
$707.28 |
| 90671 |
|
40 |
39 |
$620.20 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
343 |
339 |
$605.28 |
| 81025 |
|
442 |
423 |
$542.46 |
| 85651 |
|
161 |
143 |
$497.95 |
| 90620 |
|
288 |
263 |
$496.44 |
| 81002 |
|
310 |
290 |
$460.77 |
| 96160 |
|
13,849 |
12,773 |
$456.09 |
| 90474 |
|
57 |
55 |
$456.00 |
| 87807 |
|
91 |
91 |
$454.83 |
| 87428 |
|
29 |
27 |
$408.24 |
| 85014 |
|
519 |
489 |
$382.32 |
| 69209 |
|
39 |
38 |
$381.48 |
| 69200 |
|
13 |
13 |
$322.84 |
| 90480 |
|
77 |
77 |
$301.54 |
| 82465 |
|
338 |
330 |
$233.28 |
| 77072 |
|
25 |
25 |
$198.19 |
| 98960 |
|
20 |
15 |
$99.26 |
| 93225 |
|
16 |
16 |
$98.20 |
| 36416 |
|
15,525 |
13,237 |
$90.70 |
| G9920 |
Screening performed and negative |
3,754 |
3,702 |
$59.00 |
| 90744 |
|
327 |
306 |
$58.78 |
| 74018 |
|
13 |
12 |
$45.36 |
| 99406 |
|
29 |
28 |
$42.90 |
| 90713 |
|
215 |
214 |
$42.54 |
| 81000 |
|
32 |
31 |
$38.64 |
| 90647 |
|
461 |
402 |
$35.25 |
| 99172 |
|
103 |
98 |
$34.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
373 |
367 |
$33.05 |
| 90649 |
|
49 |
49 |
$28.36 |
| 82962 |
|
13 |
13 |
$26.66 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
592 |
544 |
$19.98 |
| 3210F |
|
648 |
625 |
$14.18 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
154 |
150 |
$14.18 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
50 |
37 |
$12.98 |
| 90380 |
|
124 |
124 |
$5.00 |
| A9150 |
Non-prescription drugs |
150 |
142 |
$0.04 |
| 91307 |
|
3,089 |
2,699 |
$0.01 |
| 91312 |
|
12 |
12 |
$0.00 |
| 4124F |
|
407 |
382 |
$0.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
57 |
57 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
35 |
35 |
$0.00 |
| 90710 |
|
100 |
99 |
$0.00 |
| 4131F |
|
17 |
17 |
$0.00 |
| S9470 |
Nutritional counseling, dietitian visit |
210 |
202 |
$0.00 |
| 91308 |
|
39 |
26 |
$0.00 |
| 2010F |
|
5,185 |
4,928 |
$0.00 |
| 3079F |
|
1,350 |
1,257 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
202 |
199 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
64 |
49 |
$0.00 |
| 99174 |
|
559 |
526 |
$0.00 |
| 2030F |
|
13 |
13 |
$0.00 |
| 4056F |
|
13 |
13 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
36 |
36 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
83 |
79 |
$0.00 |
| 1000F |
|
12 |
12 |
$0.00 |
| 90381 |
|
104 |
102 |
$0.00 |
| 91305 |
|
18 |
13 |
$0.00 |
| 4058F |
|
13 |
13 |
$0.00 |